Marriage is a beautiful and lifelong commitment, but before saying “I do,” it is important for couples to undergo important ...

A new study linked soil and water pollution to the human health crisis of global heart disease, according to News Medical Life Sciences. Published in the journal Atherosclerosis, the study reviewed ...

Researchers at Harvard have identified 17 controllable factors that can reduce the risk of stroke, dementia, and depression. (Freepik) “These brain diseases are deeply connected,” said lead ...

“This high value target is a transcription factor involved in the regulation of proinflammatory cytokines serving as a central regulator of inflammation response in autoimmune diseases where targeted ...

[Lp(a)], a genetically inherited risk factor for heart disease, according to a press release Sunday. “Nearly a quarter of the world’s population has elevated levels of Lp(a), putting them at a ...

RhoGAM is a shot given to pregnant people whose blood is negative for Rhesus factor (Rh) protein but who are carrying an Rh-positive fetus. It is also called Rh immunoglobulin. If your blood is ...

Lepodisiran, an experimental drug from the pharmaceutical company Eli Lilly, is a small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) [Lp(a)], a genetically ...

Lepodisiran, an experimental drug by Eli Lilly, reduces the risk of genetic heart disease by 94% ... for patients because it eliminates a risk factor we’ve been unable to treat,” the lead ...

The experimental drug lepodisiran, developed by Eli Lilly, significantly lowered levels of the genetically inherited heart disease risk factor Lp(a) in a midstage trial. Presented at a major medical ...

[Lp(a)], a genetically inherited risk factor for heart disease. In the Phase 2 ALPACA study, lepodisiran significantly reduced Lp(a) levels by an average of 93.9% over the 60 to 180-day period ...